Viewpoint from UKPCA: From stable to critical
In Opinion
Follow this topic
Bookmark
Record learning outcomes
Greg Barton, specialist pharmacist critical care and burns, explains what pharmacists should look out for in patients with type 2 diabetes and co-existing cardiac disease
It is not uncommon for stable community-based patients to rapidly become unwell and require admission to a critical care unit or intensive care. Small changes in disease state, medication (changes in dose or new additions) or the onset of a new condition can all lead to a patient becoming acutely unwell.
A relatively common example that can be picked up and potentially prevented by a pharmacist is the type 2 diabetic with co-existing cardiac disease. These patients will generally be on metformin, a statin, an ACE inhibitor, diuretics such as furosemide and/or spironolactone and potentially a beta-blocker or angiotensin 2 antagonist.
A seemingly small or insignificant illness (e.g. a two-day history of diarrhoea or vomiting) can have a profound effect. Such patients will often present to the GP or hospital confused or drowsy as a result of dehydration and acute renal failure and can progress rapidly to multi-organ failure. They may also show up at a pharmacy requesting OTC antidiarrhoeals or electrolyte replacement sachets earlier in their illness.
A seemingly small illness can have a profound effect
On presentation to hospital it will be rapidly apparent that the patient needs critical care management. Initial blood tests often show a high serum creatinine, a breakdown product of creatine phosphate in muscle, which is excreted unchanged by the kidney and so used as a marker of renal function. This figure can be 10-20 times that of the patient's normal baseline value and would immediately trigger a referral to critical care to manage with fluids and potentially renal replacement therapy such as dialysis.
Other initial abnormal blood tests often include:
- Raised potassium €“ this may be due the renal injury but it may also be compounded by the use of ACE inhibitors, angiotensin 2 blockers or an aldosterone antagonist (e.g. spironolactone), which all have a potassium-retaining effect
- Raised creatine kinase (CK) - this is used to screen for rhabdomyolysis, where myoglobin (a large oxygen-storing protein in the muscles) is released, clogging up the kidneys and leading to potential kidney failure
- Lactic acidosis €“ this is generally attributed to the failing kidney not clearing metformin and lactate from the body. Lactic acidosis can rapidly occur €“ small deviations in blood pH, for example a drop from normal (7.4) to 7.0, can be fatal.
All of the above can often quickly combine to mean a person who was fit and well only a couple of days previously has now become a critically ill patient requiring dialysis.
If caught early enough patients often go on to make a full recovery. Monitoring and vigilance by pharmacists can help prevent the initial incidence and ensure it doesn't happen again.